These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22859528)

  • 1. Infusion reactions related to infliximab therapy are not usually associated with drug discontinuation.
    Cullen G; Cheifetz AS
    J Rheumatol; 2012 Aug; 39(8):1500-2. PubMed ID: 22859528
    [No Abstract]   [Full Text] [Related]  

  • 2. Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration.
    Toki H; Momohara S; Tsukahara S; Ikari K
    J Rheumatol; 2008 Sep; 35(9):1896-7; author reply 1897. PubMed ID: 18785300
    [No Abstract]   [Full Text] [Related]  

  • 3. Reactions to infliximab in patients with rheumatoid arthritis.
    Prupas M
    J Rheumatol; 2005 Jul; 32(7):1411; author reply 1411. PubMed ID: 15996090
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral neuropathy during infliximab therapy for rheumatoid arthritis.
    El Aidli S; Gaïes E; Cherif F; Zaiem A; Daghfous R; Lakhal M
    Presse Med; 2014 Sep; 43(9):1012-4. PubMed ID: 24742611
    [No Abstract]   [Full Text] [Related]  

  • 5. Reactions to infliximab in patients with rheumatoid arthritis.
    Sakellariou GT; Chatzigiannis I
    J Rheumatol; 2005 Jul; 32(7):1411-2. PubMed ID: 15996088
    [No Abstract]   [Full Text] [Related]  

  • 6. Infliximab induced lupus in patients with rheumatoid arthritis.
    Elkayam O; Caspi D
    Clin Exp Rheumatol; 2004; 22(4):502-3. PubMed ID: 15301255
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymyositis associated with infliximab treatment for rheumatoid arthritis.
    Urata Y; Wakai Y; Kowatari K; Nitobe T; Mizushima Y
    Mod Rheumatol; 2006; 16(6):410-1. PubMed ID: 17165006
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab therapy in established rheumatoid arthritis: an observational study.
    Voulgari PV; Alamanos Y; Nikas SN; Bougias DV; Temekonidis TI; Drosos AA
    Am J Med; 2005 May; 118(5):515-20. PubMed ID: 15866254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced lupus following treatment with infliximab in rheumatoid arthritis.
    Favalli EG; Sinigaglia L; Varenna M; Arnoldi C
    Lupus; 2002; 11(11):753-5. PubMed ID: 12475006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe herpes zoster after infliximab infusion.
    Kinder A; Stephens S; Mortimer N; Sheldon P
    Postgrad Med J; 2004 Jan; 80(939):26. PubMed ID: 14760175
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules.
    Sakai R; Tanaka M; Nanki T; Watanabe K; Yamazaki H; Koike R; Nagasawa H; Amano K; Saito K; Tanaka Y; Ito S; Sumida T; Ihata A; Ishigatsubo Y; Atsumi T; Koike T; Nakajima A; Tamura N; Fujii T; Dobashi H; Tohma S; Sugihara T; Ueki Y; Hashiramoto A; Kawakami A; Hagino N; Miyasaka N; Harigai M;
    Ann Rheum Dis; 2012 Nov; 71(11):1820-6. PubMed ID: 22504558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and adverse reactions of the TNFalpha inhibitor infliximab in rheumatoid arthritis].
    Imagama T; Taguchi T
    Nihon Rinsho; 2013 Jul; 71(7):1209-13. PubMed ID: 23961668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute coronary syndrome after infliximab infusion.
    Abedin M; Scheurich D; Reimold SC; Reimold AM
    Cardiol Rev; 2006; 14(1):50-2. PubMed ID: 16371767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrosing alveolitis after treatement of rheumatoid arthritis by infliximab].
    Nouijai A; Mounach A; Ghozlani I; Achemlal L; Bezza A; El Maghraoui A
    Presse Med; 2009 Oct; 38(10):e17-20. PubMed ID: 19447578
    [No Abstract]   [Full Text] [Related]  

  • 15. [Incidence and management of infusion reactions to infliximab in 186 italian patients with rheumatoid arthritis: the Padua experience].
    Botsios C; Ostuni P; Todesco S
    Reumatismo; 2005; 57(1):44-51. PubMed ID: 15776146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of pulmonary thromboembolism during infliximab therapy.
    Eklund KK; Peltomaa R; Leirisalo-Repo M
    Clin Exp Rheumatol; 2003; 21(5):679. PubMed ID: 14611130
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis.
    Du Pan SM; Dehler S; Ciurea A; Ziswiler HR; Gabay C; Finckh A;
    Arthritis Rheum; 2009 May; 61(5):560-8. PubMed ID: 19405000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis.
    Kent PD; Davis JM; Davis MD; Matteson EL
    Arthritis Rheum; 2002 Aug; 46(8):2257-8; author reply 2259. PubMed ID: 12209539
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody.
    Mori S; Imamura F; Kiyofuji C; Sugimoto M
    Mod Rheumatol; 2006; 16(4):251-5. PubMed ID: 16906378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe neutropenia and thrombocytopenia associated with infliximab.
    Vidal F; Fontova R; Richart C
    Ann Intern Med; 2003 Aug; 139(3):W-W63. PubMed ID: 12899609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.